<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AChina_Insurance_Regulatory_Commission</id>
	<title>Definition:China Insurance Regulatory Commission - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AChina_Insurance_Regulatory_Commission"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:China_Insurance_Regulatory_Commission&amp;action=history"/>
	<updated>2026-05-16T12:44:48Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:China_Insurance_Regulatory_Commission&amp;diff=22829&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating definition</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:China_Insurance_Regulatory_Commission&amp;diff=22829&amp;oldid=prev"/>
		<updated>2026-03-31T17:57:41Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating definition&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🇨🇳 &amp;#039;&amp;#039;&amp;#039;China Insurance Regulatory Commission&amp;#039;&amp;#039;&amp;#039; was the primary government body responsible for regulating and supervising the insurance industry in the People&amp;#039;s Republic of China from its establishment in 1998 until its absorption into the newly formed China Banking and Insurance Regulatory Commission (CBIRC) in 2018 — which itself was later reorganized into the National Financial Regulatory Administration (NFRA) in 2023. During its two decades of operation, the CIRC oversaw one of the fastest-growing insurance markets in the world, presiding over the transformation of China&amp;#039;s industry from a state-dominated sector with limited product offerings into a sprawling market encompassing [[Definition:Life insurance|life]], [[Definition:Property and casualty insurance|property and casualty]], [[Definition:Health insurance|health]], and [[Definition:Reinsurance|reinsurance]] operations involving both domestic champions and foreign joint ventures.&lt;br /&gt;
&lt;br /&gt;
🏗️ The CIRC exercised broad authority over market entry and licensing, [[Definition:Solvency|solvency]] standards, product approval, [[Definition:Premium|premium]] rate regulation, investment limits, and consumer protection across China&amp;#039;s insurance sector. One of its most significant achievements was the development and implementation of the China Risk Oriented Solvency System ([[Definition:C-ROSS|C-ROSS]]), a risk-based [[Definition:Capital adequacy|capital adequacy]] framework that drew on principles from [[Definition:Solvency II|Solvency II]] while adapting them to the characteristics of the Chinese market. C-ROSS replaced the earlier volume-based solvency regime and brought Chinese regulatory practice closer to international standards, requiring insurers to hold capital commensurate with their [[Definition:Underwriting risk|underwriting]], market, and [[Definition:Credit risk|credit risk]] exposures. The CIRC also intervened decisively to rein in aggressive short-term [[Definition:Universal life insurance|universal life]] products and high-risk investment strategies that had destabilized several prominent insurers, most notably in a series of enforcement actions during 2016–2017 that resulted in leadership removals and asset seizures at firms like Anbang Insurance Group.&lt;br /&gt;
&lt;br /&gt;
🌏 Even though the CIRC no longer exists as a standalone entity, its legacy profoundly shapes how China&amp;#039;s insurance market is regulated today. The [[Definition:C-ROSS|C-ROSS]] framework it created continues to evolve — C-ROSS Phase II took effect in 2022, imposing more granular risk charges and tighter rules on related-party transactions and asset-liability matching. For the global insurance industry, understanding the CIRC&amp;#039;s historical role is essential context for engaging with a market that ranks among the world&amp;#039;s largest by [[Definition:Gross written premium|gross written premium]] volume and continues to attract significant interest from international [[Definition:Reinsurer|reinsurers]], [[Definition:Broker|brokers]], and [[Definition:Insurtech|insurtech]] firms. The regulatory architecture the CIRC built — including its approach to foreign ownership limits, product regulation, and prudential oversight — remains the foundation upon which CBIRC and now NFRA continue to operate.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:C-ROSS]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:National Financial Regulatory Administration]]&lt;br /&gt;
* [[Definition:Gross written premium]]&lt;br /&gt;
* [[Definition:Capital adequacy]]&lt;br /&gt;
* [[Definition:Reinsurance]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>